AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...
Adverse Effects of Robotic-Assisted Laparoscopic Versus Open Retropubic Radical Prostatectomy Among a Nationwide Random Sample of Medicare-Age Men There is currently no imaging biomarker for ...
First Focal One ® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer Center OnQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results